ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 1.990
0.00 (0.00%)
At close: Jun 2, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 59.8 million as of June 10, 2026. Its market cap has decreased by -23.67% in one year.
Market Cap
59.80M
Enterprise Value
58.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
Market Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 59.80M, an increase of 314.37%. That is a compound annual growth rate of 71.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 59.80M | -50.25% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 63.16M |
| Telescope Innovations | 59.80M |
| Sernova Biotherapeutics | 56.55M |
| NurExone Biologic | 54.31M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 38.77M |
| Microbix Biosystems | 38.57M |
| Defence Therapeutics | 37.89M |